MarginsXMarginsX
Home › Markets › Health Care › FMS

Fresenius Medical Care AG (FMS)

FMS trades on NYSE in Health Care, Misc Health and Biotechnology Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$21.86
-0.77% on the day
Market cap
$12.2B
Large cap
Revenue · 2025
$21.7B
No prior year to compare
Net income · 2025
$1.1B
5.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1333141/000110465926019005/0001104659-26-019005-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31. Converted from EUR at 0.9048 per USD (today's ECB or Federal Reserve reference rate).

Profile

FieldValue
TickerFMS on NYSE
SectorHealth Care
IndustryMisc Health and Biotechnology Services
CountryGermany
IPO yearNot reported by the screener
SEC CIK0001333141
SEC industry codeServices-Misc Health & Allied Services, NEC

Financials · 2025

LineValue
Revenue$21.7B
Net income$1.1B
Operating income$2.0B
Net margin5.0%
Operating margin9.3%
Revenue growthNo prior-year revenue to compare
Cash$1.8B
Total assets$34.3B
P/E (computed)11.3×
P/S (computed)0.6×

Reported in EUR; shown in US dollars.

Warning signs

Cash runway
Cash-flow positive
$1.8B cash at December 31, 2025
Share count, 1 year
-4.8%
2024-12-31 to 2025-12-31 · -4.8% over 3 years
Going-concern doubt
No
20-F filed February 24, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-02-24
Cash and burn$1.8B cash; operating cash flow $740.8M a quarter.Report 2025-12-31
Shares outstandingNo cover-page share count in XBRLCover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft, Frankfurt, GermanyPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$21.7B$1.1B$3.0B$1.8B$11.9B$21.7B20-F 2026-02-24
FY 2016
2016-12-31
Not filed$1.2B$2.1B$747.2M$8.6BNeeds four quarters20-F 2017-02-22
FY 2015
2015-12-31
Not filed$1.0B$2.0B$549.5M$8.6BNeeds four quarters20-F 2017-02-22
FY 2014
2014-12-31
$5.3B$1.0B$1.9B$633.9M$9.5B$5.3B20-F 2015-02-25
FY 2013
2013-12-31
$5.0B$1.1B$2.0B$682.8M$8.4B$5.0B20-F 2014-02-25
FY 2012
2012-12-31
Not filed$1.2B$2.0B$688.0M$8.2BNeeds four quarters20-F 2015-02-25
FY 2011
2011-12-31
Not filed$1.1B$1.4B$457.3M$7.2BNeeds four quarters20-F 2014-02-25
FY 2010
2010-12-31
Not filed$978.5M$1.4B$522.9M$4.7BNeeds four quarters20-F 2013-02-26

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32023-06-06
Latest annual report
FORM 20-F
20-F2026-02-24
Latest quarterly / interim
FORM 6-K
6-K2026-11-09

Source: SEC EDGAR submissions feed, 602 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-5.9%
1 month+4.5%
3 months-6.8%
Year to date-7.5%
1 year-7.0%
From 52-week high-14.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Misc Health and Biotechnology Services

TickerCompanyPriceDayMarket cap
DVADaVita Inc.$174.22-0.19%$11.0B
SHCSotera Health Company$16.25-2.17%$4.6B
PGNYProgyny Inc.$37.15+2.68%$2.7B
AGLagilon health inc.$116.75+0.94%$2.0B
VMDViemed Healthcare Inc. Common Shares$9.15-0.22%$346.7M
PARKPark Dental Partners Inc.$19.72-8.24%$109.2M
CCELCryo-Cell International Inc.$4.55-6.19%$36.7M
MGRXMangoceuticals Inc.$0.1603+3.42%$3.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier